Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age
Clinical trial NCT03114943 · COMPLETED
Trial details
- NCT number
- NCT03114943
- Sponsor
- SK Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-14
- Primary completion
- 2017-06-28
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.